Literature DB >> 9925777

Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.

I Najera1, M Krieg, J Karn.   

Abstract

The structural and accessory proteins of human immunodeficiency virus type 1 are expressed by unspliced or partially spliced mRNAs. Efficient transport of these mRNAs from the nucleus requires the binding of the viral nuclear transport protein Rev to an RNA stem-loop structure called the RRE (Rev response element). However, the RRE does not permit Rev to stimulate the export of unspliced mRNAs from the efficiently spliced beta-globin gene in the absence of additional cis-acting RNA regulatory signals. The p17gag gene instability (INS) element contains RNA elements that can complement Rev activity. In the presence of the INS element and the RRE, Rev permits up to 30 % of the total beta-globin mRNA to be exported to the cytoplasm as unspliced mRNA. Here, we show that a minimal sequence of 30 nt derived from the 5' end of the p17 gag gene INS element (5' INS) is functional and permits the export to the cytoplasm of 14% of the total beta-globin mRNA as unspliced pre-mRNA. Gel mobility shift assays and UV cross-linking experiments have shown that heterogeneous nuclear ribonucleoprotein (hnRNP) A1 and a cellular RNA-binding protein of 50 kDa form a complex on the 5' INS. Mutants in the 5' INS that prevent hnRNP A1 and 50 kDa protein binding are inactive in the transport assay. To confirm that the hnRNP A1 complex is responsible for INS activity, a synthetic high-affinity binding site for hnRNP A1 was also analysed. When the high affinity hnRNP A1 binding site was inserted into the beta-globin reporter, Rev was able to increase the cytoplasmic levels of unspliced mRNAs to 14%. In contrast, the mutant hnRNP A1 binding site, or binding sites for hnRNP C and L are unable to stimulate Rev-mediated RNA transport. We conclude that hnRNP A1 is able to direct unspliced globin pre-mRNA into a nuclear compartment where it is recognised by Rev and then transported to the cytoplasm. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9925777     DOI: 10.1006/jmbi.1998.2473

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  31 in total

1.  Reduction of target gene expression by a modified U1 snRNA.

Authors:  S A Beckley; P Liu; M L Stover; S I Gunderson; A C Lichtler; D W Rowe
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Evaluation of the role of heterogeneous nuclear ribonucleoprotein A1 as a host factor in murine coronavirus discontinuous transcription and genome replication.

Authors:  X Shen; P S Masters
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

3.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS.

Authors:  Horst Wolff; Ruth Brack-Werner; Markus Neumann; Thomas Werner; Ralf Schneider
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 5.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

6.  Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity.

Authors:  Joseph A Jablonski; Massimo Caputi
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

7.  Depletion of hnRNP A2/B1 overrides the nuclear retention of the HIV-1 genomic RNA.

Authors:  Heather Gordon; Lara Ajamian; Fernando Valiente-Echeverrìa; Kathy Lévesque; William F Rigby; Andrew J Mouland
Journal:  RNA Biol       Date:  2013-09-30       Impact factor: 4.652

8.  The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation.

Authors:  A J Mouland; J Mercier; M Luo; L Bernier; L DesGroseillers; E A Cohen
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

9.  Use of biotinylated plasmid DNA as a surrogate for HSV DNA to identify proteins that repress or activate viral gene expression.

Authors:  Stephen Mallon; Bassam T Wakim; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-05       Impact factor: 11.205

Review 10.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.